Bone densitometry in the clinical practice

European Radiology

Volumn 7, Issue SUPPL. 2, 1997, Pages

  Passariello, R ^a   Albanese, C V ^a   Kvasnova M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY; ESTROGEN THERAPY; FEMALE; FRACTURE; HUMAN; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR;

BONE DENSITY; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 0002653172     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00006860     Document Type: Article

References (79)

1. Anone (1993) Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94: 646-650
2. Johnston CC Jr, Melton LJ III (1993) Bone density measurement and the management of osteoporosis. In: Favus MJ (ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. Raven Press, New York, pp 137-146
3. Garnero P, Hausherr E, Chapuy M-C, et al. (1966) Markers of bone resorption predict hip fracture in elderly women: the EPI-DOS prospective study. J Bone Miner Res 11:1531-1538.
4. Reker RR (1993) Bone biopsy and histomorphometry in clinical practice.In: Favus MJ (ed) Primer on the metabolic bone, diseases and disorders of mineral metabolism. Raven Press, New York, pp 146-150
5. Genant HK, Engelke K, Fuerst T, et al. (1996) Review. Nonivasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 11: 707-730
6. Compston JE, Cooper C, JA Kanis (1995) Bone densitometry in clinical practice. BMJ 310: 1507-1510
7. Sartoris DJ (1994) Clinical value of bone densitometry. Am J Roentgenol 163:133-135
8. Briney WG (1993) Is measurement of bone density useful? Rheum Dis Clin North Am 19: 95-106
9. Johnston CC Jr, Slemenda CW, Melton LJ III (1991) Clinical, use of bone densitometry. N Engl J Med 324:1105-1109
10. Lang P, Steiger P, Faulkner K, et al. (1991) Osteoporosis. Current techniques and recent developments in quantitative bone' densitometry. Radiol Clin North Am 29: 49-76
11. Genant HK, Block JE, Steiger P, et al. (1989) Appropiate use of bone densitometry. Radiology 170: 817-822
12. Aloia JF, Cohn SH, Vaswani A, et al. (1985) Risk factors for postmenopausal osteoporosis. Am J Med 78: 95-100
13. Stevenson JC, Lees B, Devenport M, et al. (1989) Determinants of bone density in normal women: risk factors for future osteoporosis? BMJ 298: 924-928
14. Riggs BL, Melton LJ (1983) Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 75: 899-901
15. Albanese CV, Civitelli R, Tibollo FG, et al. (1996) Endocrine and physical determinants of bone mass in late postmenopause. Exp Clin Endocrinol Diabetes 104: 263-270
16. Slemenda CW, Hui SL, Longcope C, et al. (1990) Predictors of bone mass in perimenopausal women: prospective study of clinical data using photon absorptiometry. Ann Intern Med 112: 96-101
17. Hui SL, Slemenda CW, Johnston CC (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81: 1804-1809
18. Melton W, Waher HW, Richelson LS, et al. (1986) Osteoporosis and the risk of hip fractures. Am J Epidemiol 124: 254-261
19. Mazzess RB, Wahner HW (1988). Nuclear medicine and densitometry. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis, and management. Raven Press, New York, pp 251-295
20. Ross PD, David JW, Vogel JM, et al. (1990). A critical review of bone mass and the risk of fractures in osteoporosis. Calcif Tissue Int 46: 149-161
21. Gardsell P, Johnell O, Nilsson B (1991) The predictive value of bone loss for fragility fractures in women: a longitudinal study over 15 years. Cacif Tissue Int 49: 90-94
22. Pouilles JM, Tremollieres F, Ribot C (1993) Spine and femur densitometry at the menopause: are both sites necessary in the assessment of the risk of osteoporosis. Calcif Tissue Int 52: 344-347
23. Davis JW, Ross PD, Wasnich RD (1994) Evidence for both generalized and regional low bone mass among elderly women. J Bone Miner Res 9: 305-309
24. Cummings SR, Black DM, Nevitt MC, et al. (1993) Bone density at various sites for prediction of hip fractures: the study of osteoporotic fractures. Lancet 341: 72-75
25. Wasnich R (1993) Bone mass measurement: prediction of risk. Am J Med 95: 65-105
26. Kanis JA, Melton LJ, Christiansen C, et al. (1994) The diagnosis of osteoporosis. J Bone Miner Res 9: 1137-1141
27. World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994). World Health Organ Tech Rep Ser No 843
28. Komm BS, Terpening CM, Benz DJ, et al. (1988) Estrogen binding, receptor MRNA, and biologic response in osteoblastlike osteosarcoma cells. Science 241: 81-84
29. Eriksen EF, Colvard DS, Berg NJ, et al. (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241: 84-86
30. Stevenson JC, Abeyasekera G, Hillyard CI, et al. (1981) Calcitonin and calcium regulating hormones in postmenopausal women: effect of oestrogens. Lancet I: 693-695
31. Lindsay R, Hart DM, Purdie D, et al. (1978) Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med 54: 1193-1195
32. Johnston CC Jr, Melton LJ III, Lindsay R, et al. (1989) Clinical indication for bone mass measurement. J Bone Miner Res 4[Suppl 2]:1-28
33. Grady D, Rubin SM, Petitti G, et al. (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037
34. Lindsay R, Hart DM, Forrest C, et al. (1980) Prevention of spinal osteoporosis in oophorectomized women. Lancet 2: 1151-1154
35. Stevenson JC, Kanis JA, Christiansen C (1992) Bone density measurement. Lancet 339: 370-371
36. Lachman E (1955) Osteoporosis: the potentialities and limitations of its roentgenologic diagnosis. Am J Roentgenol 74: 712-715
37. Smith RW, Rizek J (1966) Epidemiological studies of osteoporosis in women of Puerto Rico and southeastern Michigan with special reference to age, race, national origin, and to other related or associated findings. Clin Orthop 45: 31-48
38. Riggs LB, Wahner HW (1988) Bone densitometry and clinical decisison-making in osteoporosis. Ann Inter Med 108: 293-295
39. Doyle FG, Gutteridge DH, Joplin GF, Fraser R (1967) An assessment of radiological criteria used in the study of spinal osteoporosis. Br J Radiol 40: 241-250
40. Schnitzler CM, Pitchford DGK, Willis EM (1993) Comparison of the radiographic vertebral trabecular pattern with vertebral fracture prevalence and spinal bone density. Osteoporos Int 3: 293-299
41. Smith-Bindman R, Cummings SR, Steiger P, et al. (1991) A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res 6: 25-34
42. Black DM, Palermo L, Nevitt MC, et al. (1995) Comparison of method for defining prevalent vertebral deformities: the study of osteoporotic fractures. J Bone Miner Res 10: 890-902
43. Ettinger B, Black DM, Nevitt MC, et al. (1991) Contribution of vertebral deformities to chronic back pain and disability. J Bone Miner Res 7: 449-455
44. Melton LJ III, Kan SH, Frye MA, et al. (1989) Epidemiology of vertebral fractures in women. Am J Epidemiol 129: 1000-1011
45. Melton LJ III, Epidemiology of vertebral fractures (1987) In: Christianses C, Johansen JS, Riis BJ (eds) Osteoporosis. Osteopress ApS, Denmark, pp 33-37
46. Gutin B, Kasper MJ (1992) Can vigorous exercise play a role in osteoporosis prevention? A review. Osteoporos Int 2: 55-69
47. Tilyard MW, Spears GFS, Thomson G, et al. (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. New Engl J Med 326: 357-362
48. Albanese CV, Zeppilli P, Salvatore M, et al. (1990) Role of calcium intake and exercise on the bone mineral density. In: Christianses C, Overgaard K (eds) Osteoporosis. Osteopress ApS, Denmark, pp 1185-1187
49. Chapuy MC, Arlot ME, Dubocuf F, et al. (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. New Engl J Med 327: 1637-1642
50. Overgaad KY, Hansen MA, Jensen SB, et al. (1992) Effect of salcaltonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 305: 556-561
51. Liberman UA, Weiss SR, Helmut GB, et al. (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333: 1437-1443
52. Schenk R, Eggli P, Fleisch H, et al. (1986) Quantitative morphometric evaluation of the inhibitory activity af new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 38: 342-349
53. Chambers TJ, Dunn CJ (1983) Pharmacological control of osteoclast motility. Calcif Tissue Int 35: 566-570
54. Albanese CV, Cudd A, Argentino L, et al. (1994) Ipriflavone directly inhibits osteoclastic activity. Biochem Biophys Res Comm 199: 930-936
55. Riggs BL, Seeman E, Hodgson SF, et al. (1982) Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: Comparison with conventional therapy. N Engl J Med 306: 446-450
56. Riggs BL, O'Fallon WM, Hodgson SF, et al. (1994) Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extend observations and additional analysis. J Bone Min Res 9: 265-275
57. Marie P, De Vernejoul MC, Lomri A (1992) Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro. J Bone Miner Res 7: 103-113
58. Adami S, Ortolani S, Wasnich R (1995) Evaluation of therapeutic efficacy in osteoporosis. Osteoporos Int 5: 75-78
59. Heaney RP (1986) En recherche de la difference (p < 0.05)*. Bone Miner 1:99-114
60. Cummings SR, Black D (1987) Should perimenopausal women be screened for osteoporosis? Ann Inter Med 104: 817-823
61. Gluer CC, Steiger P, Selvidge R (1990) Comparative assessment of dual-photon absorptiometry and dual-energy radiography (1990). Radiology 174: 223-228
62. Mazess R, Chesnut CH III, McClung M, et al. (1992) Enhanced precision with dual-energy X-ray absorptiometry. Calcif Tissue Int 51: 14-17
63. Fuleihan GEH, Testa MA, Angell JE, et al. (1995) Reproducibility of DXA absorptiometry: a model for bone loss estimates. J Bone Miner Res 10: 1004-1014
64. Jackson JA, Kleerekoper M (1990) Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine 69: 137-152
65. Albanese CV, Barone C, Astazi P, et al. (1990) Osteoporosis in premenopausal women treated with adjuvant chemotherapy for breast cancer. In: Christianses C and Overgaard K (eds) Osteoporosis. Osteopress ApS, Denmark, pp 1721-1723
66. Diamond T, Stiel D, Posen S (1991) Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemocromatosis. J Bone Miner Res 6: 39-43
67. Christiansen P, Steiniche T, Mosekilde L, et al. (1990) Primary hyperparathyroidism: changes in trabecular bone remodelling following surgical treatment evaluated by histomorphometric methods. Bone 11: 75-79
68. Bilezikian JP(1993) Primary hyperparathyroidism. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Raven Press, New York, pp155-159
69. Sealby PL, Peacock M (1986) Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in post-menopausal women. N Engl J Med 314: 1481-1485
70. Albanese CV, Salvatore M, Citterio F, et al. (1990) Bone mineral density, serum osteocalcin and parathyroid hormone in renal transplanted and haemodialized patients. In: Christianses C, Overgaard K (eds) Osteoporosis. Osteopress ApS, Denmark, pp 1724-1727
71. Copley JB, Hui SL, Leapman S, et al. (1993) Longitudinal study of bone mass in end-stage renal disease patients: effects of parathyroidectomy for renal osteodistrophy. J Bone Miner Res 8: 415-422
72. Ringe JD (1989) Glucocorticoid-induced osteoporosis. Clin Rheum 8: 109-115
73. Pocock NA, Eisman JA, Dunstan CR, et al. (1987) Recovery from steroid-induced osteoporosis. Ann Intern Med 107: 319-323
74. Olgaard K, Storm T, Wooeren N, et al. (1992) Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: A double-blind study on the high-dose, long term effects of prednisone versus deflazacort. Calcif Tissue Int 50: 490-497
75. Need AG (1987) Corticosteroids and osteoporosis. Aus N Z J Med 17: 267-272
76. Hahn TJ (1993) Steroid and drug-induced osteoporosis In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Raven Press, New York, pp 250-255
77. Lukert BP, Johnson BE, Robinson RG (1992) Estrogen and progesterone replacement theraphy reduces glucocorticoid-induce bone loss. J Bone Miner Res 7: 1063-1069
78. Montemurro L, Schiraldi G, Fraioli P, et al. (1991) Prevention of corticosteroid-induced osteoporosis with salmon calcitonin. Calcif Tissue Int 49: 71-76
79. Reid IR, Schooler BA, Steward AW (1990) Prevention of glucocorticoid-induced osteoporosis. J Bone Miner Res 5: 619-623